LVIS showcases expanded NeuroMatch capabilities and ai-driven EEG advances at AES Conference. Atlanta, GA - January 15, 2026 - LVIS Corporation returned to the American Epilepsy Society (AES) Conference for the third consecutive year, continuing to build momentum around the evolution of its NeuroMatch platform through live software demonstrations and clinician engagement. Building on its growing presence at AES, LVIS highlighted meaningful advances in EEG technology and physician-focused innovation. Throughout the conference, LVIS Corporation connected with neurologists, epileptologists, and EEG professionals who recognized the significant expansion of NeuroMatchs feature set, shaped by three successive FDA clearances over the past three years. These advancements reflect LVISs ongoing focus on improving the clinical EEG experience through intelligent system design and physician-supportive tools. Attendees expressed strong interest in NeuroMatchs AI-assisted methods that help reduce artifact interference, support event detection, and provide source-localized EEG visualization. These capabilities are designed to help physicians interpret complex EEG data more efficiently while maintaining clinical confidence in their diagnostic workflow. NeuroMatchs interactive 3D and 4D visualization tools were a focal point of the demonstrations. The platform enables clinicians to explore EEG signals through animated, source-localized views that support deeper insight into neurological activity. These visualization methods are specifically developed to assist in diagnosis and treatment planning for patients requiring neurological care. "The conversations we had at AES reinforced how much demand there is for EEG technology that truly supports physicians at the point of interpretation," said Dr. Jin Hyung Lee. "Seeing clinicians engage with NeuroMatchs AI-supported tools and advanced visualization methods confirmed that thoughtful technology design can meaningfully improve how neurological data is understood and applied in patient care." LVIS Corporation remains committed to advancing neurological diagnostics through responsible AI integration, physician-centered workflows, and continuous platform innovation. The company is honored to contribute to the ongoing effort to improve access to advanced neurological care worldwide. For more information about NeuroMatch and LVIS Corporation, visit https://lviscorp.com/en/. About LVIS Corporation LVIS Corporation, headquartered in Palo Alto, California, is a leader in neurotechnology, committed to advancing patient care through innovative AI-driven solutions in neurological diagnostics and treatment. For more information or to schedule a demonstration, visit www.lviscorp.com.

LVIS Corporation launches AI platform that simplifies ambulatory review for effortless clinical workflows.